Biovirtus Research Sitesp. z o.o. in liquidation
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 529 days for 2020).
- 202511/07/2026
- 202410/07/2025
- 202303/07/2024
- 202217/07/2023
- 202103/10/2022
- 202028/03/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Biovirtus Research Site has been an NFZ healthcare provider since 2015. In 2024 it is performing 2 contracts with a total value of USD 16.87k. All its contracts were worth USD 94.80k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2024 |
|---|---|---|---|
| Podstawowa Opieka Zdrowotna | mazowieckie | 1 | USD 16.87k |
| Pilot programmes | mazowieckie | 1 | USD 0.00 |
Trademarks
Biovirtus Research Site holds 4 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2017.
| Mark | Protected until | |
|---|---|---|
| BioVirtus Research Site | Jul 2, 2028 | |
| BioVirtus(word) | Feb 3, 2027 | |
| BioVirtus Research Site(word) | Feb 3, 2027 | |
| Bio Virtus | Feb 3, 2027 | |
| Bio Virtus Research Site | – |
Authorized Representatives
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,000 | $27,012.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 3, 2023 | Call to creditors | |
| Mar 3, 2023 | Call to creditors |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,816$4,816 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,286$6,286 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,100$5,100 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-01-11 | Name change (Biovirtus Research Site → Biovirtus Research Site Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2022-12-29 | Liquidation opened | |
| 2017-02-22 | Address change (Mokra 7, 05-830, Kajetany → Ul. Augustyna Locciego 5/2, 02-928, Warszawa) | |
| 2016-08-17 | PKD change (Removed: 4 codes; Added: 5 codes) | |
| 2016-04-18 | PKD change (Removed: 13 codes; Added: 1 code) |
FAQ
Last updated: 2026-10-04